What Is the Future of Psychedelics?

Micro-dosing, therapeutic psychedelics and a Q&A with Molecular Biologist, Nick Milne, PhD

A few days ago I scrolled past a peculiar ad. I’m never sure what exactly the Instagram algorithm gods have in store for me, but here I was, staring into the void of what my micro-dosed brain could look like.

I fundamentally don’t like the idea that I am a little worker bee who needs to ingest psychedelics to increase my productivity (and thus increase the profit of whoever is hiring me). If I am not productive enough to keep up without psychedelics, then the system is flawed and my workload should decrease.

Is micro-dosing psychedelics the latest fad in a trend that has us spending our money and potentially sacrificing our health in an attempt to increase our value in the labour market?

But, on the flip side, I see that the therapeutic potential for psychedelics is absolutely huge (I just don’t agree with applying them to make us “better” workers).

Psychedelics were re-popularised in 1957 following one serendipitous vacation to Mexico when an American banker and mushroom enthusiast brought back a sample of psychoactive mushrooms to the US. Later, he sent them to a Swiss chemist, Albert Hoffman, who is known for discovering LSD. Hoffman started producing psilocybin (the psychedelic component) for research purposes.

Related posts:

A murder charge related to a death at a downtown Yellowknife sobering centre has been downgraded to assault causing bodily harm after new evidence was received from the coroner’s office. Jerry…

Comic Relief was founded in 1985 as a humanitarian response to the Ethiopian Famine. Over 30 years later the charity has been able to raise 1 billion pounds, however, it continues to be recognised as…